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ABSTRACT

This study sought to explore the relationship between Parkinson’s Disease (PD), the
amygdala, and the plethora of non-motor symptoms that plague individuals with PD. Previous
research gave insights about the amygdala’s function as the emotional center of the brain, its role
in depression, and its participation in the non-motor symptoms of PD. The research proved to
still be inconclusive on its own because of a variety of limitations. The methods of this study
consist of the analysis of Functional Magnetic Resonance Imaging (fMRI) scans from 93
individuals with PD and 18 individuals without PD while in a resting state. The analysis showed
that the amygdalae experienced decreased functional connectivity (FC) to the right posterior
areas of the superior frontal gyrus (SFG). Because this depletion of FC is similar to the
neurological effects of Major Depression Disorder (MDD), it is suggested that depression in PD
is caused by the amygdala’s inability to communicate effectively with the right posterior SFG.
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INTRODUCTION
Parkinson's Disease (PD) is more than just a motor disorder. A myriad of non-motor
symptoms plague many patients diagnosed with PD such as psychosis, sleep deprivation, and
depression (Chaudhuri et. al., 2006). These are extremely serious symptoms and Chaudhuri et. al.
(2006) pointed out that these symptoms could potentially be even more detrimental to a person’s
quality of life than the motor symptoms of PD would be. This study hopes to explore the
relationship between the amygdala and the non-motor symptoms of PD.
The amygdala is a complex entity comprised of several interconnected nuclei that each
have their own function, yet seamlessly transfer information to the rest of the brain. Though this
might seem an impossible enigma, researchers have made great strides toward understanding the
amygdala and its functions. Pessoa (2010), for example, explained how the amygdala contributes
to human and non-human brains having the capacity for vigilance, arousal, attention, and
decision making. Pessoa (2010) also focused on the amygdala’s division of labor. Pessoa (2010)
noted that the “basolateral amygdala appears to be responsible for Pavlovian learning and the
representation of value”. The research of Cardinal et. al. (2002) supported Pessoa’s claim about
the basolateral amygdala’s connection to Pavlovian conditioned stimuli. This article primarily
focused on how the amygdala is connected to conditioned responses. The article noted that the
amygdala is the brain’s emotion center (Cardinal et. al., 2002). The researchers also stated that
the purpose of the amygdala's emotional response is to enhance decision making and to facilitate
conditioned responses over time (Cardinal et. al., 2002). Therefore, the amygdala is not only the
brain's emotional center but also the motivational center.
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Koelsch and Skouras (2013) explored the initial emotional response to a stimulus and the
lingering effects. The main conclusion from the results of the experiment was that the superficial
amygdala is extremely central for the neural pathways for joy (Koelsch & Skouras, 2013).
Although it is widely accepted that the amygdala is the brain’s emotional center, Pessoa (2010)
states that the amygdala is known for being the brain’s center for fear-based conditioning.
Therefore, the results from Koelsch and Skouras (2013) are surprising because joy elicited a
much more active response not only in the superficial amygdala but in all nuclei of the
amygdala.
In another article that took interest in the amygdala’s relationship to PD, Tessitore et. al.
(2013) hypothesized that due to the known deficiency of dopamine in PD, the amygdala would
probably be affected. One of the most interesting conclusions to come out of this experiment is
that comorbid depression with PD could be another symptom of PD due to its effect on the
amygdala (Tessitore et. al., 2013). While this study did appear to suggest that there is a direct
connection between PD and MDD , Tessitore et. al. (2013) were adamant that more research is
needed in this area before that conclusion can be either confirmed or denied.
Similarly, Cardoso et. al. (2009) examined the connection between PD and depression.
Although the amygdala was not the primary focus of the study, the researchers noted its reactions
to the antidepressants (Cardoso et. al., 2009). They noted that typically the amygdala is the
source of depression, and when treated, its volume should increase (Cardoso et. al., 2009).
However, when the patients with PD were given antidepressants, the volumes of their
amygdala’s remained constant (Cardoso et. al., 2009). Harding et. al.'s (2002) study attempted to
focus on which sector of the amygdala PD directly attacks. This study claimed to have
2
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determined that a disordered amygdala is a consistent symptom in PD and that there is a
correlation between increasing Lewy Body presence throughout the entire amygdala and mild
neuronal cell loss (Harding et. al., 2002). They also found some evidence to suggest that Lewy
Bodies in the amygdala could be the cause of visual hallucinations in the later stages of PD
(Harding et. al., 2002). Harding et. al. (2002) noted that depression is normally linked to the
disordered amygdala just as the disordered amygdala is linked to PD. The researchers noted that
the general understanding of MDD is that the amygdala experiences increased activity (Harding
et. al., 2002). Harding et. al. (2002) also pointed to other studies (de la Monte et al., 1989; Cordato
et al., 2000) that showed that the amygdala experiences atrophy when PD is present. However,

this contradicts what Hung et. al. (2015) reported in their findings. Their results showed that the
amygdalae's volumes were approximately the same within each group of participants (Hung et.
al., 2015). The contradiction was likely a result of the different participants’ conditions. Harding
et. al.'s (2002) participants were deceased, and PD likely had been present longer in these
individuals, increasing the severity of the disease. Whereas participants in Hung et. al.’s (2015)
study were still living and had only recently been diagnosed with PD. The contradictory results
and conclusions of these studies display the need for more research.
Hung et. al. (2015) also suggested that the amygdala is more active in people with PD and
experiences a significant loss in FC to areas of the brain such as the frontal lobe, temporal lobe,
and basal ganglia. This result is similar to what Harding et. al. (2002) discovered about MDD.
There is also significant uncertainty about the efficacy of treatments for non-motor
symptoms associated with PD. Chaudhuri et. al. (2006) noted that while there are a plethora of
non-motor symptoms of PD such as depression, little research exists concerning treatment
3
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options for these symptoms. Elefant et. al. (2012) hypothesized that music therapy could treat the
depressive symptoms of PD. This hypothesis could be supported by the amygdala’s connection
to depression in PD and its link to expressing joy after exposure to joyful music (Koelsch and
Skouras, 2013). However, the results of the study displayed improvement only in the motorrelated symptoms of PD (Elefant et. al., 2012). Although the results were ineffective in treating
depressive symptoms associated with PD, the ineffectiveness suggests that PD directly affects
the amygdala, rendering the structure unable to process joy from music or any other source.
The combination of these findings and conclusions opens the door to new questions and
considerations. It has suggested that there is possibly a connection between PD, the amygdala,
and the non-motor symptoms of PD, but more research is required to solidify this connection.
The research question that this study seeks to answer is this: how does PD affect the functional
connectivity of the amygdala?
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METHODS
Data Acquisition
The Parkinson's Progression Markers Initiative provided the MRI images, the clinical data,
and the demographic data (Marek et al., 2011). Functional MRI data during the resting state was
available for 93 individuals with PD (61.27±10.36 years old) and 18 individuals without PD
(64.17±9.96 years old).
Echo planar image (EPI) volumes of the resting state had 40 slices of 4mm 68x66 matrix
with 3.3mm thickness (voxel size = 3.29x3.29x3.3mm), with a repetition time (TR) of 2400ms
and echo time (TE) of 25ms. This analysis used a total of 210 volumes (8.4 minutes) and highresolution structural T1 volumes as 176 sagittal slices of 240mm x 256mm with 1mm thickness
(voxel size = 1x1x1mm, TR=2300ms and TE=2.98ms).
Data Processing
Previously published methods (Kiparizoska & Ikuta, 2017) with FMRIB Software Library
(FSL,) as well as Analysis of Functional NeuroImages (AFNI) dictated the methods of data
preprocessing and statistical analyses. The anatomical volume for each subject was skull
stripped, segmented into gray matter, white matter, and cerebrospinal fluid (CSF), and registered
to the MNI 2mm standard brain after removing the first four EPI volumes. To remove transient
signal spikes, de-spiking interpolation was used. The volumes were linearly registered to the first
volume, through which six motion parameters and displacement distance between two
consecutive volumes were estimated to account for head motion. Each of the resting state
volumes regressed by white matter, cerebrospinal fluid signal fluctuations, and the six motion
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parameters. Then the volumes were resampled and spatially transformed and aligned to the MNI
2mm standard brain space, after smoothing with a 6mm full width at half maximum (FWHM)
Gaussian kernel. Thus, 12 affine parameters were created between the resting-state fMRI volume
and MNI152 2mm space, so that the processed EPI volume could later be registered to the MNI
space. As a displacement distance between two EPI volumes, the root mean square deviation was
calculated from motion correction parameters, at an r=40mm spherical surface using FSL’s
rmsdiff tool. This was done to perform scrubbing so that the volumes whose displacement
distance exceeded the threshold (0.3mm) because of motion are removed from further statistical
analyses.
The left and right amygdalae were identified in the Harvard-Oxford Subcortical atlas [12]
on the MNI 2mm space. The purpose of this was to conduct voxel-wise FC analysis of the
primary auditory cortices. A voxel-wise connectivity analysis was performed from the bilateral
amygdala seed to the entire brain. The time course was spatially averaged within the amygdalae
that is registered to the EPI space. Then, correlations could be tested between the amygdalae and
each voxel across the brain. The correlations between the amygdalae and each voxel across the
whole brain were represented by Z scores that were used for group-level analysis after
registration to the MNI 2mm brain space. The time course was spatially averaged within the
cluster that showed group voxel-wise association with the amygdalae.
Randomise script in FSL in paired-T test fashion adjusted for the time between two groups
by comparing the two resting-state fMRI sessions. Threshold-free cluster enhancement (TFCE)
of p<0.05 was used to estimate the contrast images.
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RESULTS
The amygdalae of the PD group showed decreased FC to the right posterior medial areas
of the superior frontal gyrus (SFG) [MNI: 10, 12, 56] when compared to the control group. The
PD group did not display any greater connectivity within the brain in comparison to the
connectivity of the control group.
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DISCUSSION
The purpose of the study was to determine the role of the amygdala of non-motor
symptoms associated with PD. The results of the study led to the discovery that the amygdala’s
effect on non-motor symptoms in PD is not necessarily dependent on its hypertrophy or
hypotrophy but rather its FC to the SFG. The function of the SFG is not entirely defined in the
current research. Alagapan et. al (2018) noted that previous research had not yet identified the
role of the SFG, but the researchers attempted to link the left SFG’s function to working memory.
Their results supported their hypothesis; however, there is still much to be learned about the
function of the SFG (Alagapan et. al., 2018). Cao et. al. (2020) demonstrated research that
showed how the left SFG contributes to short-term memory recall and discussed how the left
SFG showed a reduction in grey matter volume (GMV) during the early stages of PD and that
this could account for the functional changes. Chen et. al. (2018) also concluded that GMV is
decreased in the left SFG in patients with major depressive disorder (MDD). These results were
compared to patients with Bipolar Disorder instead of a control group (Chen et. al., 2018).
While the previous studies listed have interesting information and theories about the
function of the left SFG, the present study found the FC from the amygdala to the right posterior
medial sectors of the SFG to be lacking. Falquez et. al. (2014) consider how brain-damaged
individuals are able or not able to make use of self-focused reappraisal. This process allows
people to detach from negative experiences they have been through and feelings of guilt. The
researchers suggest that the right SFG is essential for this process to work correctly (Falquez et.
al., 2014). A person’s inability to detach from their negative emotions about themselves could
logically contribute to a sense of depression. Liao et. al.’s (2020) research supports this
8
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conclusion. This article reaffirms that the SFG experiences a reduction in connectivity in patients
with PD (Liao et. al., 2020). It also suggests that this connection, or rather deficit in connection,
is a major harbinger of depression in PD (Liao et. al., 2020).
Hernández et. al. (2018) were curious about how the natural diminishing volume and
surface area of the SFG affects the cognitive functioning of individuals who have cognitive
disorders such as Alzheimer’s Disease over 2 years. Even though the volume and surface area of
the SFG decreased over the 2 years, the results of the cognitive tests remained the same
(Hernández et. al., 2018). Dipple et. al. (2017) attempted to determine the neural pathways for
inhibitory control processes which allow for focus and successful, task-oriented behavior. The
study determined that the SFG was likely a key component of this neural process (Dipple et. al.,
2017). The qualities of inhibitory control directly oppose apathetic qualities. Alexopoulos et. al.
(2012) noted that apathy is extremely common in older adults and often coincides with
depression. These researchers explored how the brain’s FC in older adults specifically affects
apathy in Major Depressive Disorder (MDD). They discovered that apathetic depressed adults
showed decreased FC in both the amygdala and SFG (Alexopoulos et. al., 2012). This finding is
similar to the findings of the current study which specifies that the FC is decreased directionally
from the amygdala to the right posterior SFG in individuals with PD.
The limitations of this study are that it does not monitor the participants over a long
period of time to show how the participants’ FC could continue to change. The study also has no
knowledge of whether the participants in either the PD group or the control group have ever been
diagnosed with MDD separately or in conjunction with PD. The number of participants is also
too small to produce conclusive evidence, and the amygdalae’s volumes are unknown. These
9

PARKINSON’S DISEASE, THE AMYGDALA, AND NON-MOTOR SYMPTOMS
limitations suggest that future research should analyze fMRI scans of more participants over long
periods of time with a group with PD, a group with MDD, a group with both PD and MDD, and
a control group with neither. The study should also take into account the volumes of the
amygdalae.

10

PARKINSON’S DISEASE, THE AMYGDALA, AND NON-MOTOR SYMPTOMS
CONCLUSION
Although it could easily be assumed that depression in conjunction with PD is due to
difficult circumstances caused both motor and non-motor symptoms, PD and MDD involve
similar neurological components. Both disorders present with significant FC deficiencies
regarding the amygdala and the SFG. Because PD and MDD share such similar neurological
qualities and are often diagnosed comorbidly, it is possible that a successful treatment for one
disease or disorder could also be an effective treatment for the other. This study also displays that
depression in relation to PD is likely not simply a situational emotion but a serious neurological
condition.
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